These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15155159)

  • 1. Strategies for long-term gene expression in the skin to treat metabolic disorders.
    Jensen TG
    Expert Opin Biol Ther; 2004 May; 4(5):677-82. PubMed ID: 15155159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes.
    Lu Z; Ghazizadeh S
    Exp Dermatol; 2005 Oct; 14(10):727-35. PubMed ID: 16176280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin genetically engineered as a bioreactor or a 'metabolic sink'.
    Christensen R; Jensen UB; Jensen TG
    Cells Tissues Organs; 2002; 172(2):96-104. PubMed ID: 12426486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to achieve long-term expression in skin gene therapy.
    Therrien JP; Pfützner W; Vogel JC
    Toxicol Pathol; 2008 Jan; 36(1):104-11. PubMed ID: 18337228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors.
    Nguyen TH; Mainot S; Lainas P; Groyer-Picard MT; Franco D; Dagher I; Weber A
    Curr Gene Ther; 2009 Apr; 9(2):136-49. PubMed ID: 19355871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in skin gene therapy.
    Pfützner W; Vogel JC
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2069-83. PubMed ID: 11060793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated cutaneous gene delivery: the skin as a bioreactor.
    Cao T; Wang XJ; Roop DR
    Hum Gene Ther; 2000 Nov; 11(16):2297-300. PubMed ID: 11084689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous gene therapy--an update.
    Christensen R; Jensen UB; Jensen TG
    Histochem Cell Biol; 2001 Jan; 115(1):73-82. PubMed ID: 11219611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preclinical model for the analysis of genetically modified human skin in vivo.
    Del Rio M; Larcher F; Serrano F; Meana A; Muñoz M; Garcia M; Muñoz E; Martin C; Bernad A; Jorcano JL
    Hum Gene Ther; 2002 May; 13(8):959-68. PubMed ID: 12031128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy.
    Larcher F; Dellambra E; Rico L; Bondanza S; Murillas R; Cattoglio C; Mavilio F; Jorcano JL; Zambruno G; Del Rio M
    Mol Ther; 2007 Sep; 15(9):1670-6. PubMed ID: 17579576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-directed gene transfer and application to therapy.
    Sandig V; Strauss M
    J Mol Med (Berl); 1996 Apr; 74(4):205-12. PubMed ID: 8740651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin, a privileged target for gene therapy].
    Descamps V
    Presse Med; 1995 May; 24(19):882-4. PubMed ID: 7638126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermis: an attractive target tissue for gene therapy.
    Greenhalgh DA; Rothnagel JA; Roop DR
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):63S-69S. PubMed ID: 7963687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating and regulating immune responses through cutaneous gene delivery.
    Larregina AT; Falo LD
    Hum Gene Ther; 2000 Nov; 11(16):2301-5. PubMed ID: 11084690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous gene transfer and therapy: the present and the future.
    Spirito F; Meneguzzi G; Danos O; Mezzina M
    J Gene Med; 2001; 3(1):21-31. PubMed ID: 11269332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for metabolic disorders.
    Kay MA; Woo SL
    Trends Genet; 1994 Jul; 10(7):253-7. PubMed ID: 8091506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase.
    Braun-Falco M; Eisenried A; Büning H; Ring J
    Arch Dermatol Res; 2005 May; 296(11):528-35. PubMed ID: 15776248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral vectors: a look back and ahead on gene transfer technology.
    Vannucci L; Lai M; Chiuppesi F; Ceccherini-Nelli L; Pistello M
    New Microbiol; 2013 Jan; 36(1):1-22. PubMed ID: 23435812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive drug delivery.
    Blömer U; Ganser A; Scherr M
    Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.